Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897650 · ClinicalTrials.gov registry record
Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer
A clinical trial of Lung Cancer, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 204
- Enrollment target
- 1
- Study location
NCT00897650 is a study of Lung Cancer that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 204 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00897650, a study of Lung Cancer, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Studying samples of tumor tissue and blood in the laboratory from patients with cancer may help doctors learn more about changes that occur in genetic material (DNA and RNA) and may also identify protein expression patterns related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study evaluates changes in DNA, RNA, and proteins with the goal of predicting response to treatment in patients with lung cancer.
Conditions Studied
Interventions
- PROCEDURE Blood sample
- GENETIC DNA/RNA sequencing and expression levels
- GENETIC Protein expression analysis
- PROCEDURE Lung tumor biopsy
Study Locations (1)
Tennessee
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2005-12 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897650
The ClinicalTrials.gov registry entry for NCT00897650 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (78% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Blood sample is the first listed.
NCT00897650 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00897650 about?
NCT00897650 is a clinical study titled "Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer". RATIONALE: Studying samples of tumor tissue and blood in the laboratory from patients with cancer may help doctors learn more about changes that occur in genetic material (DNA and RNA) and may also identify protein expression patterns related to cancer. It may also help doctors predict how patients ...
What is the current status of trial NCT00897650?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2005-12. Estimated completion is 2017-07.
What conditions does trial NCT00897650 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00897650?
The interventions under investigation include: Blood sample (PROCEDURE), DNA/RNA sequencing and expression levels (GENETIC), Protein expression analysis (GENETIC), Lung tumor biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00897650?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00897650 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.